Nilay Thakkar

611 total citations
17 papers, 467 citations indexed

About

Nilay Thakkar is a scholar working on Oncology, Infectious Diseases and Virology. According to data from OpenAlex, Nilay Thakkar has authored 17 papers receiving a total of 467 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 6 papers in Infectious Diseases and 4 papers in Virology. Recurrent topics in Nilay Thakkar's work include Drug Transport and Resistance Mechanisms (6 papers), HIV/AIDS drug development and treatment (6 papers) and HIV/AIDS Research and Interventions (5 papers). Nilay Thakkar is often cited by papers focused on Drug Transport and Resistance Mechanisms (6 papers), HIV/AIDS drug development and treatment (6 papers) and HIV/AIDS Research and Interventions (5 papers). Nilay Thakkar collaborates with scholars based in United States, South Korea and United Kingdom. Nilay Thakkar's co-authors include Wooin Lee, A. Craig Lockhart, Kim L. R. Brouwer, Song‐Hee Han, Daniel González, Kyungbo Kim, Christoph P. Hornik, Sara Salerno, Kyung-Hwa Kim and Nipun B. Merchant and has published in prestigious journals such as PLoS ONE, The FASEB Journal and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Nilay Thakkar

16 papers receiving 459 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nilay Thakkar United States 9 198 117 79 68 59 17 467
Beatrix Wulkersdorfer Austria 17 240 1.2× 123 1.1× 97 1.2× 129 1.9× 83 1.4× 48 714
P. J. McKiernan United Kingdom 16 77 0.4× 229 2.0× 86 1.1× 124 1.8× 42 0.7× 40 792
M Wettstein Germany 14 155 0.8× 204 1.7× 155 2.0× 83 1.2× 47 0.8× 27 728
Jacqueline L. Olin United States 13 92 0.5× 117 1.0× 61 0.8× 17 0.3× 41 0.7× 36 468
Melanie de la Cruz United States 6 234 1.2× 108 0.9× 42 0.5× 114 1.7× 83 1.4× 7 401
Svetlana Markova United States 3 196 1.0× 122 1.0× 28 0.4× 94 1.4× 40 0.7× 6 416
Taiji Sawamoto Japan 17 159 0.8× 100 0.9× 160 2.0× 59 0.9× 101 1.7× 30 644
François A. Leblond Canada 13 125 0.6× 113 1.0× 37 0.5× 115 1.7× 16 0.3× 22 632
G Fredj France 11 180 0.9× 84 0.7× 55 0.7× 51 0.8× 26 0.4× 40 483
Shinji Kobuchi Japan 13 198 1.0× 122 1.0× 26 0.3× 28 0.4× 33 0.6× 61 529

Countries citing papers authored by Nilay Thakkar

Since Specialization
Citations

This map shows the geographic impact of Nilay Thakkar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nilay Thakkar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nilay Thakkar more than expected).

Fields of papers citing papers by Nilay Thakkar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nilay Thakkar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nilay Thakkar. The network helps show where Nilay Thakkar may publish in the future.

Co-authorship network of co-authors of Nilay Thakkar

This figure shows the co-authorship network connecting the top 25 collaborators of Nilay Thakkar. A scholar is included among the top collaborators of Nilay Thakkar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nilay Thakkar. Nilay Thakkar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Thakkar, Nilay, Rulan Griesel, Amy Pierce, et al.. (2025). Clinical Pharmacokinetics and Safety of a New HIV-1 Capsid Inhibitor, VH4004280, After Oral Administration in Adults Without HIV. Infectious Diseases and Therapy. 14(6). 1313–1326. 2 indexed citations
2.
Thakkar, Nilay, Rulan Griesel, Amy Pierce, et al.. (2025). Clinical Pharmacokinetics and Safety of Orally Administered VH4011499, a New HIV-1 Capsid Inhibitor, in Adults Without HIV. Infectious Diseases and Therapy. 14(5). 1011–1025. 2 indexed citations
3.
Salem, Farzaneh, Dung N. Nguyen, Mark Bush, et al.. (2024). Development of a physiologically based pharmacokinetic model of fostemsavir and its pivotal application to support dosing in pregnancy. CPT Pharmacometrics & Systems Pharmacology. 13(11). 1881–1892. 4 indexed citations
4.
Thakkar, Nilay, Mindy Magee, Navin Goyal, et al.. (2023). Model‐Based Dose Selection of Fostemsavir for Pediatric Populations With Multidrug‐Resistant HIV‐1 and Relative Bioavailability Assessment in Healthy Adults. Clinical Pharmacology in Drug Development. 12(10). 991–1000.
5.
6.
Thakkar, Nilay, Justin A. Green, Gavin Koh, et al.. (2018). Population Pharmacokinetics of Tafenoquine, a Novel Antimalarial. Antimicrobial Agents and Chemotherapy. 62(11). 16 indexed citations
7.
Thakkar, Nilay, Ji Eun Park, Song‐Hee Han, et al.. (2017). The N-terminal region of organic anion transporting polypeptide 1B3 (OATP1B3) plays an essential role in regulating its plasma membrane trafficking. Biochemical Pharmacology. 131. 98–105. 15 indexed citations
8.
Thakkar, Nilay, et al.. (2017). Effect of Liver Disease on Hepatic Transporter Expression and Function. Journal of Pharmaceutical Sciences. 106(9). 2282–2294. 90 indexed citations
9.
Thakkar, Nilay, Jeffrey T. Guptill, Kathy L. Aleš, et al.. (2017). Population Pharmacokinetics/Pharmacodynamics of 3,4‐Diaminopyridine Free Base in Patients With Lambert‐Eaton Myasthenia. CPT Pharmacometrics & Systems Pharmacology. 6(9). 625–634. 8 indexed citations
10.
Thakkar, Nilay, Daniel González, Michael Cohen‐Wolkowiez, et al.. (2016). An opportunistic study evaluating pharmacokinetics of sildenafil for the treatment of pulmonary hypertension in infants. Journal of Perinatology. 36(9). 744–747. 10 indexed citations
11.
Thakkar, Nilay, Sara Salerno, Christoph P. Hornik, & Daniel González. (2016). Clinical Pharmacology Studies in Critically Ill Children. Pharmaceutical Research. 34(1). 7–24. 45 indexed citations
12.
13.
Thakkar, Nilay, A. Craig Lockhart, & Wooin Lee. (2015). Role of Organic Anion-Transporting Polypeptides (OATPs) in Cancer Therapy. The AAPS Journal. 17(3). 535–545. 86 indexed citations
14.
Goff, Laura W., Nilay Thakkar, Liping Du, et al.. (2014). Thymidylate Synthase Genotype-Directed Chemotherapy for Patients with Gastric and Gastroesophageal Junction Cancers. PLoS ONE. 9(9). e107424–e107424. 80 indexed citations
15.
Wang‐Gillam, Andrea, Nilay Thakkar, A. Craig Lockhart, et al.. (2014). A phase I study of pegylated liposomal doxorubicin and temsirolimus in patients with refractory solid malignancies. Cancer Chemotherapy and Pharmacology. 74(2). 419–426. 4 indexed citations
16.
Han, Song‐Hee, Kyungbo Kim, Nilay Thakkar, Donghak Kim, & Wooin Lee. (2013). Role of hypoxia inducible factor-1α in the regulation of the cancer-specific variant of organic anion transporting polypeptide 1B3 (OATP1B3), in colon and pancreatic cancer. Biochemical Pharmacology. 86(6). 816–823. 26 indexed citations
17.
Thakkar, Nilay, Kyungbo Kim, Eun Ryoung Jang, et al.. (2012). A Cancer-Specific Variant of the SLCO1B3 Gene Encodes a Novel Human Organic Anion Transporting Polypeptide 1B3 (OATP1B3) Localized Mainly in the Cytoplasm of Colon and Pancreatic Cancer Cells. Molecular Pharmaceutics. 10(1). 406–416. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Beatrix Wulkersdorfer Breakdown of academic impact, for papers by P. J. McKiernan Breakdown of academic impact, for papers by M Wettstein Breakdown of academic impact, for papers by Jacqueline L. Olin Breakdown of academic impact, for papers by Melanie de la Cruz Breakdown of academic impact, for papers by Svetlana Markova Breakdown of academic impact, for papers by Taiji Sawamoto Breakdown of academic impact, for papers by François A. Leblond Breakdown of academic impact, for papers by G Fredj Breakdown of academic impact, for papers by Shinji Kobuchi
Rankless by CCL
2026